The SPARK model for translational research has proven to be a successful paradigm which can be replicated at other academic institutions
SPARK Global - SPARKing Everywhere
Strength in numbers: SPARK programs have been established or are under development in a dozen academic institutions throughout the world, increasing the likelihood that new treatments will be developed from research across the globe.
With SPARK Global, we also created a network of like-minded scientists in academia that can be recruited quickly to address global health challenges when they arise.
SPARK's Partnerships with Academic Institutions
The SPARK model for translational research has proven to be a successful program which can be replicated at other academic institutions as a cost-effective way to facilitate development of research discoveries into novel therapeutics or diagnostics.
A number of academic institutions have successfully developed their own SPARK programs based upon the SPARK at Stanford model. SPARK at Stanford actively supports our US and international partners in the development of their programs with visits, guest lectures, and more.
Key requirements for SPARK success:
- Strong foundation in basic and clinical research
- Local resource of highly skilled industry advisors
- Seed money to fund drug development projects
Other critical components:
- Multiple voices—don’t rely on a single expert
- On campus—bring industry experts and academics together in a single room
- Open exchange—with no hierarchy
- Ongoing—so that learning accumulates and response to challenges is immediate
- Sharing failure—so that others will learn and avoid it
SPARK Around the World
Please contact us for more information about starting a SPARK program at your institution.
Global Opportunities to Collaborate
There are numerous SPARK projects open for partnering and business opportunities. Explore the projects and reach out.
SPARK Global Events
SPARK has hosted events with our partners around the world.
A number of academic institutions have successfully developed their own SPARK programs.
Since 2006 we have funded nearly 130 projects, which led to 25 startups, 10 licensing and 30 clinical trials.